Afinitor Disperz is a Oral Tablet, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Everolimus.
| Product ID | 0078-0628_0ced2a29-15c1-4c3a-b89c-777f1297918c |
| NDC | 0078-0628 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Afinitor Disperz |
| Generic Name | Everolimus |
| Dosage Form | Tablet, For Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2012-08-29 |
| Marketing Category | NDA / NDA |
| Application Number | NDA203985 |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | EVEROLIMUS |
| Active Ingredient Strength | 5 mg/1 |
| Pharm Classes | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],mTOR Inhibitor Immunosuppressant [EPC],mTOR Inhibitors [MoA],Decreased Immunologic Activity [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2012-08-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA203985 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2012-08-29 |
| Marketing Category | NDA |
| Application Number | NDA203985 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2012-08-29 |
| Ingredient | Strength |
|---|---|
| EVEROLIMUS | 5 mg/1 |
| SPL SET ID: | 2150f73a-179b-4afc-b8ce-67c85cc72f04 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0078-0628 | Afinitor Disperz | Afinitor Disperz |
| 0078-0626 | Afinitor Disperz | Afinitor Disperz |
| 0078-0627 | Afinitor Disperz | Afinitor Disperz |
| 0054-0470 | Everolimus | Everolimus |
| 0054-0471 | Everolimus | Everolimus |
| 0054-0472 | Everolimus | Everolimus |
| 0054-0480 | Everolimus | Everolimus |
| 0054-0481 | Everolimus | Everolimus |
| 0054-0482 | Everolimus | Everolimus |
| 0054-0497 | Everolimus | Everolimus |
| 0054-0604 | Everolimus | Everolimus |
| 0078-0414 | Zortress | everolimus |
| 0078-0415 | Zortress | everolimus |
| 0078-0417 | Zortress | everolimus |
| 0078-0422 | Zortress | everolimus |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() AFINITOR 79059629 3639863 Dead/Cancelled |
Novartis AG 2008-09-02 |
![]() AFINITOR 79023992 3216047 Live/Registered |
Novartis AG 2006-03-23 |
![]() AFINITOR 77675030 3785901 Dead/Cancelled |
Novartis AG 2009-02-20 |
![]() AFINITOR 77540495 3778903 Dead/Cancelled |
Novartis AG 2008-08-06 |